Form 4: Alignment Healthcare CEO John Kao Acquires 330,000 Shares of Common Stock

Alignment Healthcare's CEO, John Kao, acquired 330,000 shares of common stock on March 13, 2024, and holds a total of 2,642,253 directly and 2,723,100 indirectly.

Summary

• John Kao, the CEO of Alignment Healthcare, acquired 330,000 shares of common stock on March 13, 2024.
• The acquisition was in the form of restricted stock units, each representing the right to receive one share of Alignment Healthcare's common stock.
• These restricted stock units will vest 25% on each of the first four anniversaries of the grant date, contingent upon Mr. Kao's continued service to the company.
• Following the transaction, Mr. Kao directly owns 2,642,253 shares of common stock.
• Mr. Kao also indirectly owns 2,723,100 shares through the JEK Trust, dated February 8, 2021, for which he serves as trustee.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard regulatory filing detailing stock transactions. The CEO's purchase could be seen as a positive signal, but it's not overtly promotional.

Positives

• The CEO's acquisition of shares may signal confidence in the company's future performance.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders.

Stakeholder Impact

• The CEO's increased stake in the company could align his interests more closely with those of shareholders.

Key Dates